Quick Takeaways
- Nine Ten Capital Management LLC filed SCHEDULE 13G for iRadimed Corp Common (IRMD).
- Disclosed ownership: 7.1%.
- Date of event: 31 Dec 2024.
Nine Ten Capital Management LLC - 31 Dec 2024 SCHEDULE 13G Report for iRadimed Corp Common (IRMD)
- Filing Manager
- Nine Ten Capital Management LLC
- Reporting Manager
- Nine Ten Capital Management
- Security
- iRadimed Corp Common
- Symbol
- IRMD
- Shares outstanding
- 12,759,521 shares
- Disclosed Ownership
- 905,926 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Feb 2025, 13:28:33 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 10 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Nine Ten Capital Management LLC disclosed 7.1% ownership in iRadimed Corp Common (IRMD) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2025, 13:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nine Ten Capital Management | 7.1% | 905,926 | 905,926 | 0 | Michelle Katauskas | CCO/CCO | |
| Nine Ten Partners LP | 7.1% | 905,926 | 905,926 | 0 | Nine Ten Partners LP | LP | |
| Russell Mollen | 7.1% | 905,926 | 905,926 | 0 | Russell Mollen | President |